Bharat Parenterals Ltd.BSE: BPLPHARMA

Financial Results For The Quarter And Half Year Ended On September 30,2026.

· Issued by Bharat Parenterals Ltd. via BSE India

Filed with BSE · ISIN INE365Y01019 · · 16 pages · English

Summary by 6ix AI

The report highlights significant growth, with consolidated revenue more than doubling compared to the previous year, and a notable expansion in EBITDA margin. Profit after tax also returned to positive figures, contrasting with a loss in the same quarter last year.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Script Code: 541096 SUB: OUTCOME OF THE BOARD MEETING. 1. Approved and took on record the Un-audited Standalone and Consolidated Financial Results as per Indian Accounting Standards (IND AS) along-with the Limited Review Report and Management Discussion and Analysis Report for the quarter and half year ended September 30, 2026; The meeting of Board of Directors commenced at 03:00 p.m. and conclude

Bharat Parenterals Ltd. on 6ix

In the deck

Story so far

Earlier from Bharat Parenterals

Later from Bharat Parenterals

All Bharat Parenterals news releases